A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

Francis J. Giles, Roberto Rodriguez, Daniel Weisdorf, John R. Wingard, Paul J. Martin, Thomas R. Fleming, Stuart L. Goldberg, Elias J. Anaissie, Brian J. Bolwell, Nelson J. Chao, Thomas C. Shea, Mark M. Brunvand, William Vaughan, Finn Petersen, Mark Schubert, Hillard M. Lazarus, Richard T. Maziarz, Margarida Silverman, Roy A. Beveridge, Rebecca RedmanJanis G. Pulliam, Patricia Devitt-Risse, Henry J. Fuchs, David D. Hurd

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences